Health care

Oregon Senate Bill 1528 aimed to require drug manufacturers to report more information annually about their patient assistance programs starting in 2028. It also directed the Oregon Health Authority to study health care and report findings to legislative committees by September 2027. However, the bill ultimately failed to pass.

Supporters of SB 1528 would argue that the bill was a step towards greater transparency in the pharmaceutical industry, helping to ensure that patients in Oregon have access to necessary assistance programs. They would emphasize the importance of the Oregon Health Authority's study in identifying gaps in health care and improving access for all residents.

Critics of SB 1528 might contend that the bill would impose unnecessary burdens on drug manufacturers, potentially leading to higher costs for consumers. They could also argue that the requirement for additional reporting could detract from the focus on more pressing health care issues that need immediate attention.